Insider Buying: Accelerate Diagnostics Director Purchases 2,900 Shares of Stock (AXDX)
Accelerate Diagnostics (NASDAQ:AXDX) Director Jack W. Schuler purchased 2,900 shares of Accelerate Diagnostics stock in a transaction dated Thursday, August 21st. The shares were purchased at an average cost of $16.79 per share, with a total value of $48,691.00. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available at this link.
Accelerate Diagnostics (NASDAQ:AXDX) traded up 12.49% on Monday, hitting $20.72. The stock had a trading volume of 588,635 shares. Accelerate Diagnostics has a 1-year low of $8.89 and a 1-year high of $31.86. The stock’s 50-day moving average is $19.44 and its 200-day moving average is $19.63. The company’s market cap is $923.8 million.
Accelerate Diagnostics, Inc, formerly Accelr8 Technology Corporation, is focused on developing and commercializing instrumentation for the rapid identification and antibiotic susceptibility testing of infectious pathogens.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.